UNITED
STATES
|
OMB
APPROVAL
|
||||||||
SECURITIES
AND EXCHANGE COMMISSION
|
OMB
Number:
|
3235-0101
|
|||||||
Washington,
D.C. 20549
|
Expires:
|
March
31, 2011
|
|||||||
Estimated
average burden
|
|||||||||
FORM
144
|
hours per response |
2.00
|
|||||||
NOTICE
OF PROPOSED SALE OF SECURITIES
|
SEC
USE ONLY
|
||||||||
PURSUANT
TO RULE 144 UNDER THE SECURITIES ACT OF 1933
|
DOCUMENT
SEQUENCE NO.
|
||||||||
CUSIP
NUMBER
|
|||||||||
ATTENTION:
Transmit for
filing 3 copies of this form concurrently with either placing an order
with a broker to execute sale or executing
a sale directly with a market maker.
|
|||||||||
1 (a) NAME OF ISSUER
(Please type or
print)
|
(b) IRS IDENT.
NO.
|
(c) S.E.C. FILE
NO
|
WORK
LOCATION
|
||||||
Transgenomic, Inc. [TBIO.OB]. | 91-1789357 | 000-30975 | |||||||
1
(d) ADDRESS OF
ISSUER
|
STREET |
CITY
|
STATE
|
ZIP
CODE
|
(e) TELEPHONE
NO
|
||||
12325 Emmet Street |
OMAHA
|
NE
|
68164
|
(402) 452-5400
|
|||||
2 (a) NAME OF PERSON FOR WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD |
(b) RELATIONSHIP TO
ISSUER
|
(c) ADDRESS STREET |
CITY
|
STATE
|
ZIP
CODE
|
||||
Debra A. Schneider |
CFO
|
16605 Jackson St. |
OMAHA
|
NE
|
68118
|
3
(a)
|
(b)
|
SEC
USE ONLY
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
Title
of the
|
|
|
Number
of Shares
|
Aggregate
|
Number
of Shares
|
Approximate
|
Name
of Each
|
Class
of
|
Name
and Address of Each Broker Through Whom the
|
Broker-Dealer
|
or
Other Units
|
Market
|
or
Other Units
|
Date
of Sale
|
Securities
|
Securities
To Be Sold
|
Securities
are to be Offered or Each Market Maker
|
File
Number
|
To
Be Sold
|
Value
|
Outstanding
|
(See
instr. 3(f))
|
Exchange
|
who
is Acquiring the Securities
|
(See
instr. 3(c))
|
(See
instr. 3(d))
|
(See
instr. 3(e))
|
(MO.
DAY YR.)
|
(See
instr. 3(g))
|
||
COMMON
STOCK
|
|
100,000
|
65,000
|
100,000
|
6/16/10
|
OTC.BB
|
INSTRUCTIONS:
|
|
|
|
|||
1.
|
(a)
|
Name
of issuer
|
3.
|
(a)
|
Title
of the class of securities to be sold
|
|
(b)
|
Issuer’s
I.R.S. Identification Number
|
(b)
|
Name
and address of each broker through whom the securities are intended to be
sold
|
|||
(c)
|
Issuer’s
S.E.C. file number, if any
|
(c)
|
Number
of shares or other units to be sold (if debt securities, give the
aggregate face amount)
|
|||
(d)
|
Issuer’s
address, including zip code
|
(d)
|
Aggregate
market value of the securities to be sold as of a specified date within 10
days prior to filing of this notice
|
|||
(e)
|
Issuer’s
telephone number, including area code
|
(e)
|
Number
of shares or other units of the class outstanding, or if debt securities
the face amount thereof outstanding, as shown by the most recent report or
statement published by the issuer
|
|||
(f)
|
Approximate
date on which the securities are to be sold
|
|||||
2.
|
(a)
|
Name
of person for whose account the securities are to be sold
|
(g)
|
Name
of each securities exchange, if any, on which the securities are intended
to be sold
|
||
(b)
|
Such
person’s relationship to the issuer (e.g., officer, director, 10%
stockholder, or member of immediate family of any of the
foregoing)
|
|
|
|||
(c)
|
Such
person’s address, including zip code
|
Potential
persons who are to respond to the collection of information contained in
this form are not required to respond unless the form displays a
currently valid OMB control number.
|
SEC
1147 (08-07)
|
Title
of
the
Class
|
Date
you
Acquired
|
Nature
of Acquisition Transaction
|
Name
of Person from Whom Acquired
(If gift, also give date donor
acquired)
|
Amount
of
Securities
Acquired
|
Date
of
Payment
|
Nature
of Payment
|
Common
Stock
|
6/15/10
|
Stock option
exercise
|
Transgenomic,
Inc.
|
100,000
|
6/15/10
|
Check
|
|
|
|
|
|
|
|
INSTRUCTIONS:
|
If the securities were purchased
and full payment therefor was not made in cash at the time of purchase,
explain in the table or in a note thereto the nature of the consideration
given. If the consideration consisted of any note or other obligation, or
if payment was made in installments describe the arrangement and state
when the note or other obligation was discharged in full or the last
installment paid.
|
Name
and Address of Seller
|
Title
of Securities Sold
|
Date
of Sale
|
Amount
of
Securities
Sold
|
Gross
Proceeds
|
NONE
|
|
|
|
INSTRUCTIONS:
|
ATTENTION:
|
|
See
the definition of “person” in paragraph (a) of Rule 144. Information is to
be given not only as to the person for whose account the securities are to
be sold but also as to all other persons included in that definition. In
addition, information shall be given as to sales by all persons whose
sales are required by paragraph (e) of Rule 144 to be aggregated with
sales for the account of the person filing this notice.
|
The
person for whose account the securities to which this notice relates are
to be sold hereby represents by signing this notice that he does not know
any material adverse information in regard to the current and prospective
operations of the Issuer of the securities to be sold which has not been
publicly disclosed. If such person has adopted a written trading plan or
given trading instructions to satisfy Rule 10b5-1 under the Exchange Act,
by signing the form and indicating the date that the plan was adopted or
the instruction given, that person makes such representation as of the
plan adoption or instruction date.
|
6/15/10
|
/s/ Debra A.
Schneider
|
|||
DATE
OF NOTICE
|
(SIGNATURE)
|
|||
|
||||
DATE
OF PLAN ADOPTION OR GIVING OF INSTRUCTION, IF RELYING ON RULE
10B5-1
|
The
notice shall be signed by the person for whose account the securities are
to be sold. At least one
copy
of the notice shall be manually signed. Any copies not manually signed
shall bear typed or printed
signatures.
|
ATTENTION: Intentional
misstatements or omission of facts constitute Federal Criminal Violations
(See 18 U.S.C. 1001)
|